Suki, a prominent player in the healthcare technology sector, has secured $70 million in Series D funding, bringing its total capital to $165 million.
Suki recently completed a successful funding round, raising $70 million in Series D funding. This brings their total capital to an impressive $165 million. The funding round was led by Hedosophia, with contributions from existing investors such as Venrock, March Capital, Flare Capital, Breyer Capital, and inHealth Ventures.
Suki plans to use the funding to enhance its product development efforts. Their flagship product, Suki Assistant, utilizes generative AI to streamline administrative tasks for clinicians. This innovative technology has been shown to improve documentation efficiency by up to 72%.
Suki has formed strategic partnerships with leading health systems, including MedStar Health. These partnerships allow Suki to collaborate and innovate in order to improve patient care. By reimagining the healthcare technology stack, Suki aims to reduce the administrative burden on clinicians.
The recent funding will enable Suki to diversify its capabilities and deepen relationships with strategic partners. This positions Suki well to capitalize on the growing demand for AI solutions in healthcare.